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Background
Histamine H1 receptor antagonists are used for the
treatment of allergic disorders such as allergic rhinitis
and atopic allergy with remarkable success. However,
the influence of antihistamines on the function of eosi-
nophils, which are the most important final effector
cells in allergic diseases, is not well understood.
Methods
The influence of histamine H1 receptor antagonists on
eosinophil functions was examined through the choice
of levocetirizine hydrochloride (LH) in vivo.Patients with
Japanese cedar pollinosis were orally treated with LH
once a day at a single dose of 5 mg for two weeks dur-
ing Japanese cedar pollen season (February 2012 to
April 2012). Nasal secretions were obtained before and
after treatment with the filter paper method. Eosinophil
activation was assessed by measuring the levels of both
ECP and MBP in nasal secretions by ELISA. We also
examined the number of eosinophils in nasal secretions
and IgE levels in peripheral blood obtained from
patients before and after treatment with LH.
Results
Oral administration of LH could not suppress both per-
ipheral blood eosinophila and IgE hyper-production. On
the other hand, ECP and MBP levels in nasal secretions
decreased significantly after treatment with LH. LH
treatment also favorably modified the clinical conditions
of patients: the clinical symptom scores, such as sneez-
ing, nasal discharge and congestion decreased signifi-
cantly after treatment with LH.
Conclusions
These results may suggest that LH exerts inhibitory
effects on eosinophil activation and results in favorable
modification of clinical status of pollinosis patients.
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